Managers / Q4 2023 · view latest →
Waverton Investment Management Ltd
CIK 0001344114 · 16 BABMAES STREET, LONDON, X0, SW1Y 6AH · 00 44 207484 7484
Summary
Waverton Investment Management Ltd reported $4.1B in U.S.-listed holdings across 96 positions for Q4 2023.
Its largest position, MSFT, represents 6.9% of the portfolio.
Compared with Q3 2023, the fund opened 26 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 86.6% · $3.6B
- Other · 9.7% · $398M
- ADR · 2.1% · $88M
- ETP · 0.9% · $36M
- REIT · 0.8% · $31M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| URIUnited Rentals Inc Com US$0.01 | NEW | +212.5K | 212.5K | +$122M | $122M |
| TPLTexas Pacific Land Corporation (TPL) $0.01 | NEW | +3.4K | 3.4K | +$5M | $5M |
| NVDANvidia Corporation US$0.001 | NEW | +3.7K | 3.7K | +$2M | $2M |
| FNVFranco Nevada Corp Com Npv | NEW | +11.9K | 11.9K | +$1M | $1M |
| LMTLockheed Martin Corp Com US$1.00 | NEW | +2.5K | 2.5K | +$1M | $1M |
| ADIAnalog Devices Inc Com US$0.16 | NEW | +5.5K | 5.5K | +$1M | $1M |
| DHRDanaher Corp. US$0.01 | NEW | +4.6K | 4.6K | +$1M | $1M |
| iShares Trust S&P 500 Index Fund | NEW | +1.7K | 1.7K | +$804,697 | $804,697 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2025 | $0 | 1 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $7.8B | 101 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $7.3B | 105 | Aug 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $6.5B | 102 | Apr 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $6.3B | 101 | Feb 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $6.1B | 98 | Nov 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $5.3B | 94 | Aug 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $4.8B | 94 | May 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $4.1B | 96 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $3.5B | 72 | Nov 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $3.5B | 73 | Aug 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 81 | Apr 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 79 | Feb 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $2.4B | 79 | Oct 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $2.6B | 76 | Jul 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $3.0B | 74 | Apr 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $3.2B | 68 | Feb 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $2.5B | 52 | Oct 18, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.6B | 52 | Aug 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.3B | 53 | Apr 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.2B | 54 | Jan 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.0B | 52 | Oct 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.8B | 51 | Jul 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.5B | 47 | Apr 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.9B | 46 | Jan 23, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2019 | $2.0B | 76 | Oct 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $2.0B | 78 | Jul 17, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.9B | 74 | Apr 18, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.6B | 72 | Jan 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.